Steven G. Morgan

(he/him)

2

Articles

0

Comments
Canada’s long-promised yet undelivered pharmacare program may be entering the most crucial phase in its history. (Shutterstock)

Politicians come and go, but the clock is now ticking on long‑promised pharmacare

Nav Persaud, University of Toronto and Steven G. Morgan, University of British Columbia

A national procurement program for essential medicines could provide a principled, evidence-based solution to the current challenges facing a national pharmacare program in Canada.
Health Canada’s new drug licensing proposal contains no mechanism for making fast-tracked medicines affordable. THE CANADIAN PRESS/Ryan Remiorz

Canada’s misguided changes to drug regulation could fast‑track unproven medications and divert funds from other health needs

Steven G. Morgan, University of British Columbia; Aidan Hollis, University of Calgary; Christopher McCabe, Queen's University Belfast; Matthew Herder, Dalhousie University, and Mike Paulden, University of Alberta

The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.

Contact Steven for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision